MCM
AGN

Mengis Capital Management’s Allergan Inc AGN Stock Holding History

Mengis Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,470
Closed -$1.49M – 115
2016
Q3 		$1.49M Buy
6,470
+260
+4% +$59.9K 1.24% 29
2016
Q2 		$1.44M Buy
+6,210
New +$1.44M 1.27% 29

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
LCP
Legacy Capital Partners Milwaukee, Wisconsin $304M AUM 20.42% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Mengis Capital Management's AGN Position: Q4 2016 in Review

Mengis Capital Management sold out of Allergan Inc (AGN) in Q4 2016, closing a stake of 6,470 shares — an estimated $1.49M sold.

Mengis Capital Management first reported a position in AGN in Q2 2016 and held it in 2 quarters. The position peaked at $1.49M in Q3 2016. 14 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Mengis Capital Management reported no remaining Allergan Inc position as of Q4 2016 after selling out during the quarter.
  • Mengis Capital Management sold 6,470 Allergan Inc shares in Q4 2016, an estimated $1.49M.
  • Mengis Capital Management first reported a position in Allergan Inc in Q2 2016 and held it in 2 quarters.
  • Mengis Capital Management's Allergan Inc position peaked at $1.49M in Q3 2016.
  • 14 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2016.

Based on Mengis Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.